Dihydroaustrasulfone alcohol induces apoptosis in nasopharyngeal cancer cells by inducing reactive oxygen species-dependent inactivation of the PI3K/AKT pathway

被引:0
|
作者
Tan, Kok-Tong [1 ,2 ,3 ]
Shih, Yu-Hung [4 ]
Gong, Jiny Yin [5 ]
Zhang, Xiang [6 ]
Huang, Chiung-Yao [7 ]
Su, Jui-Hsin [8 ]
Sheu, Jyh-Horng [7 ]
Lin, Chi-Chen [5 ,9 ,10 ]
机构
[1] Tungs Taichung Metro Harbor Hosp, Dept Surg, Taichung 435, Taiwan
[2] Natl Chung Hsing Univ, Coll Med, Taichung 402, Taiwan
[3] Jenteh Jr Coll Med Nursing & Management, Gen Educ Ctr, Miaoli 356, Taiwan
[4] Changhua Christian Hosp, Hematooncol Div, Dept Internal Med, Changhua 500, Taiwan
[5] Natl Chung Hsing Univ, Inst Biomed Sci, iEGG & Anim Biotechnol Ctr, Taichung 402, Taiwan
[6] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden
[7] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung 804, Taiwan
[8] Natl Museum Marine Biol & Aquarium, Pingtung 944, Taiwan
[9] China Med Univ Hosp, Dept Med Res, Taichung 404, Taiwan
[10] Kaohsiung Med Univ, Sch Med, Coll Med, Dept Pharmacol, Kaohsiung 807, Taiwan
关键词
Apoptosis; Dihydroaustrasulfone alcohol; Nasopharyngeal carcinoma; Proto-oncogene proteins c-akt; Reactive oxygen species; INTENSITY-MODULATED RADIOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; MEDIATED INACTIVATION; RANDOMIZED-TRIAL; SOFT CORAL; CARCINOMA; DEATH; INHIBITION; FAMILY;
D O I
10.4196/kjpp.2023.27.4.383
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Dihydroaustrasulfone alcohol (DA), the synthetic precursor of a natural compound (austrasulfone) isolated from the coral species Cladiella australis, has shown cytotoxic effects against cancer cells. However, it is unknown whether DA has antitumor effects on nasopharyngeal carcinoma (NPC). In this study, we determined the antitumor effects of DA and investigated its mechanism of action on human NPC cells. The MTT assay was used to determine the cytotoxic effect of DA. Subsequently, apoptosis and reactive oxygen species (ROS) analyses were performed by using flow cytometry. Apoptotic and PI3K/AKT pathway-related protein expression was determined using Western blotting. We found that DA significantly reduced the viability of NPC-39 cells and determined that apoptosis was involved in DA-induced cell death. The activity of caspase-9, caspase-8, caspase-3, and PARP induced by DA suggested caspase-mediated apoptosis in DA-treated NPC-39 cells. Apoptosis-associated proteins (DR4, DR5, FAS) in extrinsic pathways were also elevated by DA. The enhanced expression of proapoptotic Bax and decreased expression of antiapoptotic BCL-2 suggested that DA mediated mitochondrial apoptosis. DA reduced the expression of pPI3K and p-AKT in NPC-39 cells. DA also reduced apoptosis after introducing an active AKT cDNA, indicating that DA could block the PI3K/AKT pathway from being activated. DA increased intracellular ROS, but N-acetylcysteine (NAC), a ROS scavenger, reduced DA-induced cytotoxicity. NAC also reversed the chances in pPI3K/AKT expression and reduced DA-induced apoptosis. These findings suggest that ROS mediates DA-induced apoptosis and PI3K/AKT signaling inactivation in human NPC cells.
引用
收藏
页码:383 / 398
页数:16
相关论文
共 50 条
  • [21] Tetraarsenic oxide induces apoptosis in U937 leukemic cells through a reactive oxygen species-dependent pathway
    Park, IC
    Park, MJ
    Woo, SH
    Lee, HC
    An, S
    Gwak, HS
    Lee, SH
    Hong, SI
    Bae, IJ
    Seo, KM
    Rhee, CH
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 23 (04) : 943 - 948
  • [22] Piperine impairs cell cycle progression and causes reactive oxygen species-dependent apoptosis in rectal cancer cells
    Yaffe, Paul B.
    Doucette, Carolyn D.
    Walsh, Mark
    Hoskin, David W.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 109 - 114
  • [23] Ursolic Acid Induces Apoptosis of Prostate Cancer Cells via the PI3K/Akt/mTOR Pathway
    Meng, Yan
    Lin, Zhao-Min
    Ge, Nan
    Zhang, Deng-Lu
    Huang, Jie
    Kong, Feng
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2015, 43 (07): : 1471 - 1486
  • [24] Curcumin induces apoptosis in human lung adenocarcinoma A549 cells through a reactive oxygen species-dependent mitochondrial signaling pathway
    Chen, Qingyong
    Wang, Yanyi
    Xu, Kedi
    Lu, Guohua
    Ying, Zheng
    Wu, Lijun
    Zhan, Jianwei
    Fang, Rui
    Wu, Yuquan
    Zhou, Jianying
    ONCOLOGY REPORTS, 2010, 23 (02) : 397 - 403
  • [25] Baicalein induced apoptosis and autophagy undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway
    Wang, Min
    Qiu, Shenglong
    Qin, Jun
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (06): : 3341 - 3352
  • [26] Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells
    Sokbom Kang
    Seung Myung Dong
    Boh-Ram Kim
    Mi Sun Park
    Barry Trink
    Hyun-Jung Byun
    Seung Bae Rho
    Apoptosis, 2012, 17 : 989 - 997
  • [27] Puquitinib mesylate (XC-302) induces autophagy via inhibiting the PI3K/AKT/mTOR signaling pathway in nasopharyngeal cancer cells
    Wang, Ke-Feng
    Yang, Hang
    Jiang, Wen-Qi
    Li, Su
    Cai, Yu-Chen
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2015, 36 (06) : 1556 - 1562
  • [28] Rafoxanide promotes apoptosis and autophagy of gastric cancer cells by suppressing PI3K /Akt/mTOR pathway
    Liu, Jia-Zhou
    Hu, Yi-Lin
    Feng, Ying
    Guo, Yi-Bing
    Li, Yi-Fei
    Yang, Jun-Ling
    Mao, Qin-Sheng
    Xue, Wan-Jiang
    EXPERIMENTAL CELL RESEARCH, 2019, 385 (02)
  • [29] Momordin Ic couples apoptosis with autophagy in human hepatoblastoma cancer cells by reactive oxygen species (ROS)-mediated PI3K/Akt and MAPK signaling pathways
    Mi, Yashi
    Xiao, Chunxia
    Du, Qingwei
    Wu, Wanqiang
    Qi, Guoyuan
    Liu, Xuebo
    FREE RADICAL BIOLOGY AND MEDICINE, 2016, 90 : 230 - 242
  • [30] 3-Bromopyruvate induces apoptosis in breast cancer cells by downregulating Mcl-1 through the PI3K/Akt signaling pathway
    Liu, Zhe
    Zhang, Yuan-Yuan
    Zhang, Qian-Wen
    Zhao, Su-Rong
    Wu, Cheng-Zhu
    Cheng, Xiu
    Jiang, Chen-Chen
    Jiang, Zhi-Wen
    Liu, Hao
    ANTI-CANCER DRUGS, 2014, 25 (04) : 447 - 455